Tag: BLRX

BLRX, LSI, FREE & Extended Watchlist

BioLineRx, Ltd. BLRX

BLRX popped our scanner this morning, and we thought we’d pass it along as it appears to be one of this morning’s most active in pre-market trading. The stock is gapping up on the heels of an early-morning press release.

It has been filling a large gap on the chart for the past several months, and we wanted to radar the stock this morning as a total fill back to levels observed this past Spring could mean significant gains from current levels.

JERUSALEM, Dec. 16, 2013 /PRNewswire via COMTEX/ — BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today promising initial results for its BL-8040 drug candidate in a Phase 2 clinical trial for patients with relapsed or refractory acute myeloid leukemia (AML). >>>Read Full PR

LSI Corp. LSI

Another stock to turn up on our morning scan is LSI. We are witnessing a heavy gap-up as the stock is currently trading up roughly 40% in pre-market trading.

At current levels in the 11.00-range, LSI qualifies for Bluesky Breakout status, so this is definitely one we want to monitor as we begin this new trading week.

FreeSeas, Inc. FREE

We are re-alerting FREE this morning. Some of you may recall back in September, when we rode this play from less than a dollar, all the way up to mid-4.00 range. The stock has generally consolidated since that time, and is now coming off of its bottom.

Chart indicators point to potentially large gains in the near future, with the MACD having just undergone a bullish cross, and the RSI sharply rising, preparing challenge the 50-line.

After yielding us gains of more than 400% the first time, we are eager to see what the current trend could produce.

Extended Watchlist:
INOL(trading at all time lows), S, BRD, AGEN, SLTM, PATH, WYY, RVLT, HNR

TGRO, WMIH, BGMD, ZGNX, NAVB & Extended Watchlist

Tiger Oil & Energy, Inc. TGRO
–
For those of you who may have missed yesterday’s morning and afternoon reports on TGRO, the stock had a marquee day, putting up one of the best performances in the whole of the OTC Markets.

On more than 20x the 3mo. average volume, TGRO bulled its way upward throughout the day, starting at a low of .36 and reaching as high as .524, good for a strong intraday move and chance for up to a 46% profit. A strong close at .52 effectively puts us on the lookout for continued momentum this morning, though as always, traders should use caution on a stock that has seen such rapid increases.

Our timely mention of TGRO (coming just a day after the stock woke up from the dead) also put us at the top of Monday’s Penny Stock Rumble:

WMI Holdings Corp. WMIH

WMIH appeared on our Blue Horseshoe Stocks blog with yesterday afternoon’s alert, at which time the stock was trading in the 1.42 area. It would go on to experience a 27% move to 1.81 in the final hours of the session.

WMIH is now heading into uncharted territory, being the highest it’s ever been. We are going to be cautious for a pullback, and in that event we’d like to see the previous resistance, our alert price of 1.42, hold as support.

SEATTLE, Dec. 9, 2013 /PRNewswire/ — WMI Holdings Corp. (WMIH) (“WMI” or the “Company”) today announced that KKR & Co. L.P. has entered into a conditional commitment letter to make a strategic investment in the Company (the “Commitment Letter”), dated December 8, 2013. >>>Read Release

BG Medicine, Inc. BGMD

We’ve also got a new item for your tickers this morning. BGMD has news out, and looks set for an interesting session as the stock is gapping up in pre-market trading, coming off of recent lows and breaking above the 50DMA (.64), a recent area of resistance.

We’ll be monitoring BGMD today as it reacts to this morning’s announcement:

WALTHAM, Mass., Dec 10, 2013 (GLOBE NEWSWIRE via COMTEX) — BG Medicine, Inc. (Nasdaq:BGMD) announced today that the Centers for Medicare and Medicaid Services (CMS) have published the final determination of the 2014 Medicare national limitation amount for the Company’s galectin-3 blood test (analyte-specific CPT(R) Code 82777) at the amount of a crosswalked test (analyte-specific CPT(R) Code 84244) whose 2014 national limitation amount is $30.01. This national limitation amount will replace the galectin-3 blood test’s national limitation amount of $17.80 that was effective in 2013.

The following are plays with FDA-related news out this morning that we’ll want to watch closely today:

Zogenix, Inc. ZGNX
FDA Approval News out this morning, monitoring for potential breakout. >>>View PR

Navidea Biopharmaceuticals, Inc. NAVB
FDA has granted “Fast Track” status for the company’s lymph node detection test. >>>View PR

Extended Watchlist:
GERN, ARIA, CNDO, RMBS, VTNC, BLRX, NWBO

ARIA, CAMT, MACK, ECPN & Extended Watchlist

ARIAD Pharmaceuticals, Inc.  ARIA

Lately, our scans have  certainly been yielding some profitable plays, and after appearing both in Friday’s extended watchlist and yesterday morning’s report, ARIA claimed its place as the next big winner to add to that list. As we approach Thursday’s holiday hiatus, we are expecting market activity to taper as people begin to travel to their holiday destinations and generally prepare for upcoming festivities. We may decide to suspend Wednesday’s newsletter, barring some unforeseen development that may need relaying.

But for now, let’s talk about the big day ARIA had for us yesterday. After opening at 4.06, the stock came back to a low of 3.92  before running up to close at 5.13. The Northerly movement continued post-market, and the stock is gapping up this morning, so we don’t want to let ARIA slip from our radars now. Remember, this stock was trading as high as the 17.00-range as recently as last month, so it still may have some ground to recover.

So far, from Friday’s low of 3.30, the bounce on ARIA has afforded us the opportunity to make up to 55% profit (at yesterday’s closing price) and we suspect that figure could continue to grow today.

Camtek Ltd.  CAMT

CAMT came off of yesterday’s extended watchlist after it had been gapping up in premarket trading, and continued to roll throughout the day. We witnessed a move from 4.11 to a high of 5.29 on 58x the 3mo. average volume, qualifying this as a serious momentum play.

It appears CAMT will gap up once again (currently trading above 6.00) so we have our eyes peeled for continued upward activity today.

Merrimack Pharmaceuticals, Inc. MACK

On November 8th, MACK appeared in our daily report, at which time we mentioned a “big gap on the chart between the 3.00-3.40 level” that would bring us excessive gains if filled. We went on to mention the key point to watch for was a break of the 3.00 mark, and we did in fact witness that event this past Friday.

The move we were watching for did come to fruition, and the party may not be over yet; the stock is currently trading in the 3.50-range, so we will be very interested to see what happens today. We’d like to see MACK hold support at the 50DMA of 3.26 in order for it to have a good chance to pile on some added gains.

El Capitan Precious Metals, Inc. ECPN

ECPN hit our scanners today as a stock coming off of a recent consolidation that followed a big run on the chart. In early October it ran off of its 52-wk low (.055) and would subsequently hit .41 (Nov 13th) before pulling back to find support at .1142 last Thursday. Since that time it has been logging higher lows and higher highs, so we’d like to see a continuation of that trend which could make ECPN fall under the category of a solid recovery play.

We prepped a video chart on ECPN, click below and take a look:

Extended Watchlist:
ECTE, IMUC, ONVO, MBIS, OTIV, ICLD, BLRX